Serum microbiome-related metabolites—including short-chain fatty acids and indole derivatives—predict outcome and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a two-timepoint LC–MS study
BackgroundDelayed cerebral ischemia (DCI) remains a major determinant of poor outcome after aneurysmal subarachnoid hemorrhage (aSAH). Growing evidence suggests that gut microbiota–derived metabolites, including short-chain fatty acids (SCFAs) and tryptophan-related indole compounds, modulate neuroi...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2026-04-01
|
| סדרה: | Frontiers in Neurology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fneur.2026.1768108/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
